International Pharmaceutical Supply Chain Imperiled Like Never Before: A Webinar Presented by Dechert LLP and Hyman, Phelps & McNamara PC

June 2, 2016

  HPM-DechertIn recent years, the level of scrutiny on foreign pharmaceutical manufacturing facilities in countries like China and India has skyrocketed—along with the demand and dependence of western countries on the supply of goods coming from those facilities. With the international pharmaceutical supply chain imperiled like never before, what can drug manufacturers do to protect themselves?

This free webinar, presented by Dechert LLP and Hyman, Phelps & McNamara P.C., will discuss recent pharmaceutical supply chain developments and what steps companies need to take to prevent and remediate compliance issues in the context of:

  • The uptick in investigations in China and India.
  • The potential impact of adverse regulatory actions against nonconforming facilities.
  • Threats Posed by Bribery and Corruption.
  • Anti-corruption compliance issues from U.S. and Asian perspectives.
  • “War stories” from recent investigations.

When

Wednesday, June 22, 2016
12:00 p.m. – 1:00 p.m. ET

Where

This presentation will be simulcast via Webex as a webinar.  Please click here to register

Speakers

Douglas B. Farquhar
Director
Hyman, Phelps & McNamara PC
Washington, D.C.

Mark I. Schwartz
Of Counsel
Hyman, Phelps & McNamara PC
Washington, D.C.

Jeremy B. Zucker
Partner
Dechert LLP
Washington, D.C.

Lewis Ho
Partner
Dechert LLP
Hong Kong

Kareena Teh
Partner
Dechert LLP
Hong Kong

Application for accreditation of this program for Continuing Legal Education (CLE) in California, Massachusetts, New Jersey, and New York is currently pending.

For questions, please contact Reiko Tate (reiko.tate@dechert.com).